Status:
RECRUITING
Analgesic Efficacy of Maxigesic in Breast Cancer Surgery
Lead Sponsor:
Yonsei University
Conditions:
Breast Cancer
Eligibility:
FEMALE
20-70 years
Phase:
NA
Brief Summary
The present study aims to find a perioperative analgesic method that provides sufficient analgesia while reducing immune compromise in cancer surgery. This study is to investigate the analgesic effect...
Eligibility Criteria
Inclusion
- Patient aged 20 to 70 years with ASA classification 1 to 3 undergoing breast cancer surgery (cancer resection or reconstruction)
Exclusion
- ASA classification 4/ allergy to acetaminophen, NSAIDs, opioid/ severe liver or renal dysfunction/ pregnancy
Key Trial Info
Start Date :
December 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 26 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06174363
Start Date
December 28 2023
End Date
December 26 2025
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
Seoul, South Korea